1 Brewster ME, "Use of2-hydroxypropyl-beta-cyclodextrin as a solubilizing and stabilizingexcipient for protein drugs" 8 (8): 792-795, 1991
2 Carrier RL, "The utility of cyclodextrinsfor enhancing oral bioavailability" 123 (123): 78-99, 2007
3 Broadhead J, "The spray drying ofpharmaceuticals" 18 (18): 1169-1206, 1992
4 Stahl K, "The effect of process variables on the degradation and physicalproperties of spray dried insulin intended for inhalation" 233 (233): 227-237, 2002
5 Carter DC, "Structure of serum albumin" 45 : 153-203, 1994
6 Peters T, "Serum albumin" 37 : 161-245, 1985
7 Uversky VN, "Rigidity of human alpha-fetoprotein tertiary structure is underligand control" 36 (36): 13638-13645, 1997
8 Johnson KA, "Preparation of peptide and protein powders forinhalation" 26 (26): 3-15, 1997
9 Huh Y, "Preparation and evaluation of spray-driedhyaluronic acid microspheres for intranasal delivery of fexofenadinehydrochloride" 40 (40): 9-15, 2010
10 Salama RO, "Preparation and evaluation of controlled release microparticlesfor respiratory protein therapy" 98 (98): 2709-2717, 2009
1 Brewster ME, "Use of2-hydroxypropyl-beta-cyclodextrin as a solubilizing and stabilizingexcipient for protein drugs" 8 (8): 792-795, 1991
2 Carrier RL, "The utility of cyclodextrinsfor enhancing oral bioavailability" 123 (123): 78-99, 2007
3 Broadhead J, "The spray drying ofpharmaceuticals" 18 (18): 1169-1206, 1992
4 Stahl K, "The effect of process variables on the degradation and physicalproperties of spray dried insulin intended for inhalation" 233 (233): 227-237, 2002
5 Carter DC, "Structure of serum albumin" 45 : 153-203, 1994
6 Peters T, "Serum albumin" 37 : 161-245, 1985
7 Uversky VN, "Rigidity of human alpha-fetoprotein tertiary structure is underligand control" 36 (36): 13638-13645, 1997
8 Johnson KA, "Preparation of peptide and protein powders forinhalation" 26 (26): 3-15, 1997
9 Huh Y, "Preparation and evaluation of spray-driedhyaluronic acid microspheres for intranasal delivery of fexofenadinehydrochloride" 40 (40): 9-15, 2010
10 Salama RO, "Preparation and evaluation of controlled release microparticlesfor respiratory protein therapy" 98 (98): 2709-2717, 2009
11 Lu D, "Poly (lactide-co-glycolide)microspheres in respirable sizes enhance an in vitro T cellresponse to recombinant mycobacterium tuberculosis antigen85B" 24 (24): 1834-1843, 2007
12 Oga´in ON, "Particleengineering of materials for oral inhalation by dry powderinhalers. I-Particles of sugar excipients (trehalose and raffinose)for protein delivery" 405 (405): 23-35, 2011
13 Lee SH, "Nano spraydrying: a novel method for preparing protein nanoparticles forprotein therapy" 403 (403): 192-200, 2011
14 Rawat S, "Molecular mechanism ofpolyethylene glycol mediated stabilization of protein" 392 (392): 561-566, 2010
15 Grenha A, "Microspheres containing lipid/chitosan nanoparticles complexesfor pulmonary delivery of therapeutic proteins" 69 (69): 83-93, 2008
16 Ye M, "Issues in long-term protein deliveryusing biodegradable microparticles" 146 (146): 241-260, 2010
17 Wangoo N, "Interaction of goldnanoparticles with protein: a spectroscopic study to monitorprotein conformational changes" 92 : 133104-, 2008
18 Wright AK, "Hydrodynamic structure of bovineserum albumin determined by transient electric birefringence" 15 (15): 137-141, 1975
19 Tayeh N, "Fluorescence spectralresolution of tryptophan residues in bovine and human serumalbumins" 50 (50): 107-116, 2009
20 "Evaluation of protein stability and in vitro permeation of lyophilized polysaccharides-based microparticles for intranasal protein delivery" ELSEVIER SCIENCE BV 416 (416): 77-84, 2011
21 "Enhancement of sustained and controlled protein release using polyelectrolyte complex-loaded injectable and thermosensitive hydrogel" ELSEVIER SCIENCE BV 76 (76): 179-188, 2010
22 Somavarapu S, "Effect of vitamin E TPGS on immune responseto nasally delivered diphtheria toxoid loaded poly(caprolactone)microparticles" 298 (298): 344-347, 2005
23 Li D, "Effect of pH on the interaction ofvitamin B12 with bovine serum albumin by spectroscopicapproaches" 83 (83): 598-608, 2011
24 Mura P, "Development of mucoadhesive films for buccal administrationof flufenamic acid: effect of cyclodextrin complexation" 99 (99): 3019-3029, 2010
25 Haeberlin B, "Cyclodextrins—useful excipients for oral peptide administration?" 137 (137): 103-110, 1996
26 Chakraborty S, "Contrasting effect of gold nanoparticles and nanorodswith different surface modifications on the structure and activityof bovine serum albumin" 27 (27): 7722-7731, 2011
27 Price NC, "Conformational issues in the characterization ofproteins" 31 (31): 29-40, 2000
28 Greenfield N, "Computed circular dichroismspectra for the evaluation of protein conformation" 8 (8): 4108-4116, 1969
29 Laemmli UK, "Cleavage of structural proteins during the assemblyof the head of bacteriophage T4" 227 (227): 680-685, 1970
30 Werle M, "Chitosan-aprotinin coated liposomes fororal peptide delivery: development, characterization and in vivoevaluation" 370 (370): 26-32, 2009
31 Cohen S, "Bioreducible poly(amidoamine)s as carriers for intracellularprotein delivery to intestinal cells" 33 (33): 614-623, 2012
32 Sivadas N, "A comparative study of a range ofpolymeric microspheres as potential carriers for the inhalation ofproteins" 358 (358): 159-167, 2008
33 "3-Diethylaminopropyl-bearing glycol chitosan as a protein drug carrier" ELSEVIER SCIENCE BV 84 (84): 585-590, 2011